Overview

Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema

Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of alitretinoin and cyclosporine in the treatment of patients with severe recurrent vesicular hand eczema.
Phase:
Phase 3
Details
Lead Sponsor:
University Medical Center Groningen
Collaborator:
ZonMw: The Netherlands Organisation for Health Research and Development
Treatments:
Alitretinoin
Cyclosporine
Cyclosporins
Tretinoin